3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide

C123H231F6N21O18 — CID 160721733

IUPAC3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
SMILESCC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)C(F)(F)F)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C19H37N3O3.C18H32F3N3O2.C18H33N3O3.C18H35N3O3.C17H33N3O3.C17H33N3O2.C16H28F3N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-14(2)24-6-4-17(5-7-24,13-23-8-10-26-11-9-23)22-16(25)12-15(3)18(19,20)21;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19/h16H,6-15H2,1-5H3,(H,20,23);14-15H,4-13H2,1-3H3,(H,22,25);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23)
InChIKeyRTEPMOFWHRUPQR-UHFFFAOYSA-N
MW2406.32 g/mol
LogP9.01
Rot. Bonds42

About 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide

3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide (PubChem CID 160721733) has the molecular formula C123H231F6N21O18 and a molecular weight of 2406.32 g/mol. Its IUPAC name is 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide.

Molecular Properties

Compound Name3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
PubChem CID160721733
Molecular FormulaC123H231F6N21O18
Molecular Weight2406.32 g/mol
Exact Mass2404.77
IUPAC Name3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide
SMILESCC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)C(F)(F)F)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1
InChIInChI=1S/C19H37N3O3.C18H32F3N3O2.C18H33N3O3.C18H35N3O3.C17H33N3O3.C17H33N3O2.C16H28F3N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-14(2)24-6-4-17(5-7-24,13-23-8-10-26-11-9-23)22-16(25)12-15(3)18(19,20)21;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19/h16H,6-15H2,1-5H3,(H,20,23);14-15H,4-13H2,1-3H3,(H,22,25);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23)
InChIKeyRTEPMOFWHRUPQR-UHFFFAOYSA-N
XLogP9.01
TPSA372.59 Ų
H-Bond Donors9
H-Bond Acceptors32
Rotatable Bonds42
Heavy Atoms168
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002406.32
LogP ≤ 59.01
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1032

Analyze 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The IUPAC name of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide (CID 160721733) is 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide.
What is the SMILES notation for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The canonical SMILES for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide is CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)(C)O)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(C)C(F)(F)F)CC1.CC(C)N1CCC(CN2CCOCC2)(NC(=O)CC(F)(F)F)CC1.CC(O)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.CCCC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC(C)(C)CC(=O)NC1(CN2CCOCC2)CCN(C(C)C)CC1.COC1(C(=O)NC2(CN3CCOCC3)CCN(C(C)C)CC2)CC1.
What is the InChIKey of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
The InChIKey is RTEPMOFWHRUPQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H37N3O3.C18H32F3N3O2.C18H33N3O3.C18H35N3O3.C17H33N3O3.C17H33N3O2.C16H28F3N3O2/c1-16(2)22-8-6-19(7-9-22,15-21-10-12-25-13-11-21)20-17(23)14-18(3,4)24-5;1-14(2)24-6-4-17(5-7-24,13-23-8-10-26-11-9-23)22-16(25)12-15(3)18(19,20)21;1-15(2)21-8-6-17(7-9-21,14-20-10-12-24-13-11-20)19-16(22)18(23-3)4-5-18;1-15(2)21-7-5-18(6-8-21,14-20-9-11-24-12-10-20)19-16(22)13-17(3,4)23;1-14(2)20-6-4-17(5-7-20,18-16(22)12-15(3)21)13-19-8-10-23-11-9-19;1-4-5-16(21)18-17(14-19-10-12-22-13-11-19)6-8-20(9-7-17)15(2)3;1-13(2)22-5-3-15(4-6-22,12-21-7-9-24-10-8-21)20-14(23)11-16(17,18)19/h16H,6-15H2,1-5H3,(H,20,23);14-15H,4-13H2,1-3H3,(H,22,25);15H,4-14H2,1-3H3,(H,19,22);15,23H,5-14H2,1-4H3,(H,19,22);14-15,21H,4-13H2,1-3H3,(H,18,22);15H,4-14H2,1-3H3,(H,18,21);13H,3-12H2,1-2H3,(H,20,23).
What are the key properties of 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide?
3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide has a molecular weight of 2406.32 g/mol, XLogP of 9.01, 42 rotatable bonds, 9 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 3-hydroxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-hydroxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3-methoxy-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;1-methoxy-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]cyclopropane-1-carboxamide;N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;4,4,4-trifluoro-3-methyl-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]butanamide;3,3,3-trifluoro-N-[4-(morpholin-4-ylmethyl)-1-propan-2-ylpiperidin-4-yl]propanamide is sourced from PubChem (CID 160721733), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).